Oncology Devices Market Report 2024-2033: Size, Share, Growth, Trends, Analysis, Demand, Forecast, Competitive Landscape

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Oncology Devices Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $298.31 billion In 2028 At A CAGR Of 18.0% :
The oncology devices market size has grown rapidly in recent years. It will grow from $128.46 billion in 2023 to $153.93 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to rising prevalence of cancer, growing aging population, increasing demand for personalized cancer treatments, genomic profiling.

The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $298.31 billion in 2028 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to minimally invasive surgical techniques, biodegradable implants, global expansion of healthcare, value-based care models, digital health integration. Major trends in the forecast period include advancements in radiation therapy, early detection technologies, advancements in oncology devices, liquid biopsies, ai-powered decision support.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=3373&type=smp

Oncology Devices Market Major Segments
The oncology devices market covered in this report is segmented -
1) By Device Type: Brachytherapy Devices, Endoscopic Devices
2) By Therapy: Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy
3) By End User: Hospitals, Cancer Research Institutes, Other End Users

Key Driver - Rising Global Cancer Cases Drive Demand For Oncology Devices And Drugs
A growing number of cancer cases across the globe is anticipated to boost the demand for the oncology devices market. Cancer is a major health problem across the globe and is the second leading cause of death in the USA. The increasing incidence of cancer is contributing to the surge in demand for oncology devices to treat cancer patients. The four most common types of cancer globally are prostate, lung, bowel, and female breast cancer, accounting for 43% of all new cancer cases. According to the American Cancer Society, there were 1.9 million new cases and 608,570 cancer deaths in 2021 in the USA. Therefore, the rise in cancer incidence is anticipated to boost the demand for the oncology drugs market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=3373&type=smp

Prominent Trend - Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers
Major companies operating in the oncology devices market are focusing on innovative products such as benchmark ultra plus system to drive revenues in their market. The benchmark ultra plus system is a fully automated and integrated platform used in pathology and diagnostic laboratories for various laboratory processes, including the preparation, staining, and imaging of tissue samples and slides. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company that manufactures oncology devices launched the benchmark ultra plus system. This system comes with a number of advances, including updated software that is more user-friendly, remote monitoring capabilities, an integrated touchscreen for an improved user experience, and a more environmentally friendly waste system and product packaging. It can deliver high-quality, urgent results to physicians and patients because of its optimized workflow, testing effectiveness, and environmentally friendly features .

Oncology Devices Market Players
Major companies operating in the oncology devices market include Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the oncology devices market in 2023. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Oncology Devices Market Report Structure
3. Oncology Devices Market Trends And Strategies
4. Oncology Devices Market - Macro Economic Scenario
5. Oncology Devices Market Size And Growth
…..
27. Oncology Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.